Evidence map›Paper›PMID 34027098›Full record

ArticleBioengineering & translational medicine2021

Non-invasive in vivo monitoring of transplanted stem cells in 3D-bioprinted constructs using near-infrared fluorescent imaging.

Soon Hee Kim, Jin Seon Kwon, Jae Gu Cho, Kate G Park, Tae Hyeon Lim, Moon Suk Kim, Hak Soo Choi, Chan Hum Park, Sang Jin Lee

Abstract read
In one paragraph

Article in Bioengineering & translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Bioprinting of gelatin-based materials for orthopedic application.Frontiers in bioengineering and biotechnology · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. NIR fluorescence imaging and treatment for cancer immunotherapy.Journal for immunotherapy of cancer · 2022
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Soon Hee KimWake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Medical Center Boulevard Winston-Salem North Carolina USA.ORCID https://orcid.org/0000-0002-7587-9414
Jin Seon KwonWake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Medical Center Boulevard Winston-Salem North Carolina USA.
Jae Gu ChoWake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Medical Center Boulevard Winston-Salem North Carolina USA.
Kate G ParkGordon Center for Medical Imaging, Department of Radiology Massachusetts General Hospital and Harvard Medical School Boston Massachusetts USA.
Tae Hyeon LimNano-Bio Regenerative Medical Institute, College of Medicine, Hallym University Chuncheon Republic of Korea.
Moon Suk KimDepartment of Molecular Science and Technology Ajou University Suwon Republic of Korea.
Hak Soo ChoiGordon Center for Medical Imaging, Department of Radiology Massachusetts General Hospital and Harvard Medical School Boston Massachusetts USA.ORCID https://orcid.org/0000-0002-7982-6483
Chan Hum ParkNano-Bio Regenerative Medical Institute, College of Medicine, Hallym University Chuncheon Republic of Korea.ORCID https://orcid.org/0000-0002-9732-361X
Sang Jin LeeWake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Medical Center Boulevard Winston-Salem North Carolina USA.ORCID https://orcid.org/0000-0002-3899-1909

Funding

Training and Dissemination CoreP41EB023833 · NIBIB · UNIV OF MARYLAND, COLLEGE PARK · PI FISHER, JOHN P · 2017 to 2021
$6.2M
Image-Guided Drug Delivery for Pancreatic Neuroendocrine Tumor.R01EB022230 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI CHOI, HAK SOO, HENARY, MAGED M · 2017 to 2020
$3.6M
Nanochelation Therapies for Iron Overload DisordersR01HL143020 · NHLBI · UNIVERSITY OF MASSACHUSETTS LOWELL · PI CHOI, HAK SOO, KIM, JONGHAN · 2018 to 2021
$2.6M
NHLBI NIH HHS R01 HL143020NIBIB NIH HHS P41 EB023833NIBIB NIH HHS R01 EB022230
6 · The paper itself

Abstract

Cell-based tissue engineering strategies have been widely established. However, the contributions of the transplanted cells within the tissue-engineered scaffolds to the process of tissue regeneration remain poorly understood. Near-infrared (NIR) fluorescence imaging systems have great potential to non-invasively monitor the transplanted cell-based tissue constructs. In this study, labeling mesenchymal stem cells (MSCs) using a lipophilic pentamethine indocyanine (CTNF127, emission at 700 nm) as a NIR fluorophore was optimized, and the CTNF127-labeled MSCs (NIR-MSCs) were printed embedding in gelatin methacryloyl bioink. The NIR-MSCs-loaded bioink showed excellent printability. In addition, NIR-MSCs in the 3D constructs showed high cell viability and signal stability for an extended period in vitro. Finally, we were able to non-invasively monitor the NIR-MSCs in constructs after implantation in a rat calvarial bone defect model, and the transplanted cells contributed to tissue formation without specific staining. This NIR-based imaging system for non-invasive cell monitoring in vivo could play an active role in validating the cell fate in cell-based tissue engineering applications.

Indexed as

near‐infrared fluorescencenon‐invasive monitoringscaffold monitoringstem cell tracking

Identifiers

PMID34027098
PMCPMC8126817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.